Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

News You Need to Know Today
How routine eye exams could predict heart attacks | 'Promising' data on TMVr among cancer patients
Tuesday, June 14, 2022
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Today's News and Trends

Seeing the future: How routine eye exams could predict heart attacks

Researchers presented their findings at the 2022 European Human Genetics Conference in Vienna. 

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

Seeing the future: How routine eye exams could predict heart attacks

Share on Twitter Share on Facebook Share on Linkedin
Researchers presented their findings at the 2022 European Human Genetics Conference in Vienna. 
READ MORE >

New insights into what causes cardiac hypertrophy—and how to treat it

“We have finally been able to pinpoint one of the key reasons why the heart muscle wall thickens," one researcher said. 

READ MORE >
boris-martinac-lab-mechanobiology-team_web-1080px.jpeg
Share on Twitter Share on Facebook Share on Linkedin

New insights into what causes cardiac hypertrophy—and how to treat it

Share on Twitter Share on Facebook Share on Linkedin
boris-martinac-lab-mechanobiology-team_web-1080px.jpeg
“We have finally been able to pinpoint one of the key reasons why the heart muscle wall thickens," one researcher said. 
READ MORE >

'Promising' new data on TMVr among cancer patients

The study's authors examined data from nearly 23,000 patients who underwent transcatheter mitral valve repair from 2014 to 2018. 

READ MORE >
Transcatheter mitral valve repair (TMVr) is associated with “promising” short-term outcomes among patients with a history of cancer, according to new research published in the American Journal of Cardiology. #TEER #TMVR
Share on Twitter Share on Facebook Share on Linkedin

'Promising' new data on TMVr among cancer patients

Share on Twitter Share on Facebook Share on Linkedin
Transcatheter mitral valve repair (TMVr) is associated with “promising” short-term outcomes among patients with a history of cancer, according to new research published in the American Journal of Cardiology. #TEER #TMVR
The study's authors examined data from nearly 23,000 patients who underwent transcatheter mitral valve repair from 2014 to 2018. 
READ MORE >

Featured Articles

TAVR vs. surgery among children and young adults with congenital heart disease

Though TAVR was once never considered a treatment option for younger patients, it is becoming more common as time goes on. 

READ MORE >
Heart
Share on Twitter Share on Facebook Share on Linkedin

TAVR vs. surgery among children and young adults with congenital heart disease

Share on Twitter Share on Facebook Share on Linkedin
Heart
Though TAVR was once never considered a treatment option for younger patients, it is becoming more common as time goes on. 
READ MORE >

FDA announces another recall of Medtronic HVAD pump implant kits—1 patient death reported

The recall includes more than 1,600 devices distributed from October 2006 to June 2021. Medtronic's HVAD system has already been associated with multiple issues, including a separate recall in 2021. 

READ MORE >
Medtronic is once again recalling its HeartWare Ventricular Assist Device (HVAD) pump implant kit, a part of the company’s HeartWare HVAD system. This is a Class I recall, which means using the device can lead to serious injury or death. The new recall includes more than 1,600 devices distributed from October 2006 to June 2021.
Share on Twitter Share on Facebook Share on Linkedin

FDA announces another recall of Medtronic HVAD pump implant kits—1 patient death reported

Share on Twitter Share on Facebook Share on Linkedin
Medtronic is once again recalling its HeartWare Ventricular Assist Device (HVAD) pump implant kit, a part of the company’s HeartWare HVAD system. This is a Class I recall, which means using the device can lead to serious injury or death. The new recall includes more than 1,600 devices distributed from October 2006 to June 2021.
The recall includes more than 1,600 devices distributed from October 2006 to June 2021. Medtronic's HVAD system has already been associated with multiple issues, including a separate recall in 2021. 
READ MORE >

In Case You Missed It

COVID-19 repercussions on cardiac services will be with us for years to come

A new study reveals the damage caused to cardiovascular programs by the COVID-19 pandemic will continue to accrue unless mitigation strategies are implemented quickly. The review found a number of people dying are at home from heart conditions. 

READ MORE >
COVID-19 can have a serious impact effecting the heart during and after infection. The ACC released expert consensus decision pathway for the evaluation and management for the cardiovascular consequences of COVID infection and long-COVID, also known by its official clinical designation as post-acute sequelae of SARS-CoV-2 infection (PASC).
Share on Twitter Share on Facebook Share on Linkedin

COVID-19 repercussions on cardiac services will be with us for years to come

Share on Twitter Share on Facebook Share on Linkedin
COVID-19 can have a serious impact effecting the heart during and after infection. The ACC released expert consensus decision pathway for the evaluation and management for the cardiovascular consequences of COVID infection and long-COVID, also known by its official clinical designation as post-acute sequelae of SARS-CoV-2 infection (PASC).
A new study reveals the damage caused to cardiovascular programs by the COVID-19 pandemic will continue to accrue unless mitigation strategies are implemented quickly. The review found a number of people dying are at home from heart conditions. 
READ MORE >

RAAS inhibitors lower risk of aneurysm rupture among patients with high blood pressure

Researchers also noted that uncontrolled hypertension, exposure to second-hand smoke and untreated type 2 diabetes were all associated with a greater rupture risk.

READ MORE >
Brain
Share on Twitter Share on Facebook Share on Linkedin

RAAS inhibitors lower risk of aneurysm rupture among patients with high blood pressure

Share on Twitter Share on Facebook Share on Linkedin
Brain
Researchers also noted that uncontrolled hypertension, exposure to second-hand smoke and untreated type 2 diabetes were all associated with a greater rupture risk.
READ MORE >

In Other News

How COVID-19 made some radiologists newly nimble with workload management

During one surge, the hospital’s CT volumes spiked to 55% higher than pre-pandemic levels—no doubt due to heavy demand for advanced chest imaging.

READ MORE >
doctors.jpg
Share on Twitter Share on Facebook Share on Linkedin

How COVID-19 made some radiologists newly nimble with workload management

Share on Twitter Share on Facebook Share on Linkedin
doctors.jpg
During one surge, the hospital’s CT volumes spiked to 55% higher than pre-pandemic levels—no doubt due to heavy demand for advanced chest imaging.
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

AI is gaining ground, but clinicians run the show | Siemens Healthineers doubles down | Electrophysiologist compensation
News Alert: FDA shares warning about heart valve tech after patient death
Cardiologist pay & productivity are up | FDA clears PE thrombectomy devices | Cardiology tech in spotlight | Gore's new approval
Cardiology salaries on the rise | The climbing costs of care | M&A trends | Siemens Healthineers, J&J make big business moves
Major MRI trends | Blood thinner recalled | When to perform PCI before TAVR | How to build a CCTA program | Steroids & the heart
CMS boosts coverage for heart failure tech | FDA approves CardioMEMS updates | LVADs linked to strokes, other risks
M&A activity in cardiology: Exploring key trends | Cardiac PET vs. SPECT | Doctors support Medicare covering TAVR for AR
Newsletter archive
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
  • Press Releases
  • Submit Press Release
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
Design by Adaptive Theme